Laboratory Co. of America (NYSE:LH) Downgraded by Citigroup
Citigroup downgraded shares of Laboratory Co. of America from a "buy" rating to a "neutral" rating in a report on Monday.
Stay updated with breaking news from Marks Schroeder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Citigroup downgraded shares of Laboratory Co. of America from a "buy" rating to a "neutral" rating in a report on Monday.
Laboratory Co. of America Holdings (NYSE:LH - Get Rating) has received an average rating of "Moderate Buy" from the eleven ratings firms that are presently covering the stock, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating and five have given a buy
AlphaCrest Capital Management LLC decreased its holdings in shares of Laboratory Co. of America Holdings (NYSE:LH – Get Rating) by 44.9% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,707 shares of the medical research company’s stock after selling 3,831 […]
YorkBridge Wealth Partners LLC lifted its stake in shares of Laboratory Co. of America Holdings (NYSE:LH – Get Rating) by 11.0% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,041 shares of the medical research company’s stock after buying an additional 103 shares during […]
Laboratory Co. of America Holdings (NYSE:LH – Get Rating) announced a quarterly dividend on Thursday, April 7th, RTT News reports. Stockholders of record on Thursday, May 19th will be paid a dividend of 0.72 per share by the medical research company on Thursday, June 9th. This represents a $2.88 dividend on an annualized basis and […]